Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Promega and Merck collaborate to develop MSI companion diagnostic for use with anti-PD-1 therapy

Promega Corporation today announced it has entered into a global collaboration with Merck, to develop Promega’s microsatellite instability technology.

From Promega Corporation 8 Nov 2019

Study assesses how geriatric assessment can influence cancer care for vulnerable older people

A Wilmot Cancer Institute-led study in JAMA Oncology shows that when physicians fully appreciate the concerns of older adults with cancer, such as function and forgetfulness, it elevates patient care and satisfaction.

7 Nov 2019

New molecule can reduce aggressiveness of embryonal central nervous system tumors

In Brazil, scientists affiliated with the Human Genome and Stem Cell Research Center (HUG-CELL) at the University of São Paulo (USP) have identified a molecule capable of reducing the aggressiveness of embryonal central nervous system tumors.

7 Nov 2019

Oxygen-deprived tumor cells have survival advantage that promotes metastasis

Using cells from human breast cancers and mouse breast cancer models, researchers at the Johns Hopkins Kimmel Cancer Center say they have significant new evidence that tumor cells exposed to low-oxygen conditions have an advantage when it comes to invading and surviving in the bloodstream.

7 Nov 2019

Researchers seek to replace metal collimators with plastic analogs made by 3D printer

Nowadays, electron beam radiotherapy is conducted using metal collimators for the formation of radiation field around a tumor and protection of healthy organs and tissues.

7 Nov 2019

Fujitsu successfully verifies AI technology to improve efficiency in cancer genomic medicine

Fujitsu has announced the results of a joint research project it has been conducting with the Institute of Medical Science at the University of Tokyo since April 2018.

6 Nov 2019

MD Anderson, Artios Pharma and ShangPharma collaborate for ATR inhibitor program

The University of Texas MD Anderson Cancer Center, Artios Pharma Limited and ShangPharma Innovation today announce the in-licensing by Artios of a small-molecule ATR inhibitor program, developed jointly by MD Anderson and ShangPharma.

6 Nov 2019

Study: Pleural effusions are linked with NSCLC and malignant mesothelioma

Cryopreserved cell-free PE fluid from 101 NSCLC patients, 8 mesothelioma and 13 with benign PE was assayed for a panel of 40 cytokines/chemokines using the Luminex system.

6 Nov 2019

New stem cell transplant lowers complications for patients with acute blood cancers

The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines in 2014 following an article in Science. Hailed by some as a revolution, even a miracle, in the field of blood stem cell transplantation, the UM171 molecule is delivering on its promise.

5 Nov 2019

Wake Forest Baptist receives $6 million to study non-pharmaceutical cancer pain management

For many people who've had cancer, severe pain can persist even after treatment ends.

5 Nov 2019

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

The Human Immune Monitoring Center at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi.

5 Nov 2019

Bariatric surgery may cut genetic risk for developing breast cancer

Women with a genetic predisposition for breast cancer were 2.5 times more likely to develop a malignancy than women with the same genetic risk who underwent bariatric or weight-loss surgery, according to a new study presented today by Cleveland Clinic Florida researchers at the 36th American Society for Metabolic and Bariatric Surgery Annual Meeting at ObesityWeek 2019.

5 Nov 2019

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

The University of Texas MD Anderson Cancer Center and Takeda Pharmaceutical Company Limited today announced an exclusive license agreement and research agreement to develop cord blood-derived chimeric antigen receptor-directed natural killer (CAR NK)-cell therapies, 'armored' with IL-15, for the treatment of B-cell malignancies and other cancers.

5 Nov 2019

Cancer risk reduces to half with over 20% weight loss in post- bariatric surgery patients

Patients with severe obesity who had bariatric or weight-loss surgery and lost more than 20% of their total weight were 50% less likely to develop cancer compared to patients who did not have as much weight loss after surgery, according to a new study presented today by Oregon Health & Science University researchers at the 36th American Society for Metabolic and Bariatric Surgery Annual Meeting at ObesityWeek 2019.

5 Nov 2019

Eisai transfers rights to Royalty Pharma relating to net sales of EZH2 inhibitor outside of Japan

Eisai Co., Ltd. announced today that it has entered into an agreement to transfer the rights to receive royalties on the sales outside of Japan for an investigational anti-cancer agent tazemetostat (generic name) to Royalty Pharma.

5 Nov 2019

ISPOR explores digital health technologies to address key health-related challenges

ISPOR, the professional society for health economics and outcomes research - explored the potential of digital health technologies to address key health-related challenges and how to best evaluate these technologies as the field evolves.

5 Nov 2019

Ocean Medical Center receives major grant to support children with multiple health issues

Hackensack Meridian Health Ocean Medical Center Foundation has been awarded a Major Grant in the amount of $10,000 from The Provident Bank Foundation to help improve the care and support provided to children and young adults with autism.

5 Nov 2019

Facts about lung cancer and ways to reduce your risk

Lung cancer is the second most common cancer in both men and women in the United States. According to the American Cancer Society, about 13% of all new cancers are lung cancers. There will be an estimated 228,000 new cases of lung cancer this year, with more than 142,000 deaths. Moreover, the 5-year survival rate is less than 20%.

4 Nov 2019

Researchers discover way to find genetic tumor information of retinoblastoma

Retinoblastoma is a cancer that forms in the light-detecting cells in the back of the eye. It often appears in children under two years of age and can lead to blindness or eye removal. Most cancers are biopsied and studied so that medical research can design targeted treatments. Unfortunately, this is not possible with retinoblastoma.

4 Nov 2019

Clinical trial tests impact of actual and virtual nature on cancer patients

Researchers at Houston Methodist Cancer Center are exploring whether exposure to nature, through either a live garden or virtual reality, can alleviate pain and distress in cancer patients undergoing chemotherapy, possibly reducing the need for prescription narcotics.

4 Nov 2019

Oncology News and Research

Further Reading

Promega and Merck collaborate to develop MSI companion diagnostic for use with anti-PD-1 therapy

Study assesses how geriatric assessment can influence cancer care for vulnerable older people

New molecule can reduce aggressiveness of embryonal central nervous system tumors

Oxygen-deprived tumor cells have survival advantage that promotes metastasis

Researchers seek to replace metal collimators with plastic analogs made by 3D printer

Fujitsu successfully verifies AI technology to improve efficiency in cancer genomic medicine

MD Anderson, Artios Pharma and ShangPharma collaborate for ATR inhibitor program

Study: Pleural effusions are linked with NSCLC and malignant mesothelioma

New stem cell transplant lowers complications for patients with acute blood cancers

Wake Forest Baptist receives $6 million to study non-pharmaceutical cancer pain management

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

Bariatric surgery may cut genetic risk for developing breast cancer

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

Cancer risk reduces to half with over 20% weight loss in post- bariatric surgery patients

Eisai transfers rights to Royalty Pharma relating to net sales of EZH2 inhibitor outside of Japan

ISPOR explores digital health technologies to address key health-related challenges

Ocean Medical Center receives major grant to support children with multiple health issues

Facts about lung cancer and ways to reduce your risk

Researchers discover way to find genetic tumor information of retinoblastoma

Clinical trial tests impact of actual and virtual nature on cancer patients

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News